Total Payments
$352,101
2024 Payments
$86,991
Companies
9
Transactions
123
Medicare Patients
723
Medicare Billing
$55,642
Payment Breakdown by Category
Consulting$306,031 (86.9%)
Other$27,452 (7.8%)
Research$10,073 (2.9%)
Travel$5,447 (1.5%)
Food & Beverage$2,627 (0.7%)
Education$471.31 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $306,031 | 47 | 86.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $27,453 | 4 | 7.8% |
| Unspecified | $10,073 | 2 | 2.9% |
| Travel and Lodging | $5,447 | 23 | 1.5% |
| Food and Beverage | $2,627 | 38 | 0.7% |
| Education | $471.31 | 9 | 0.1% |
Payments by Type
General
$342,028
121 transactions
Research
$10,073
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EnsoData, Inc. | $193,792 | 4 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $86,648 | 40 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $29,289 | 39 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $15,511 | 17 | $0 (2024) |
| Eisai Inc. | $10,323 | 13 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $9,837 | 5 | $0 (2023) |
| 3B Medical, Inc. | $4,750 | 3 | $0 (2024) |
| Biogen, Inc. | $1,375 | 1 | $0 (2022) |
| Allergan Inc. | $575.00 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $86,991 | 12 | EnsoData, Inc. ($80,000) |
| 2023 | $161,258 | 38 | EnsoData, Inc. ($80,000) |
| 2022 | $64,287 | 20 | EnsoData, Inc. ($33,793) |
| 2021 | $22,705 | 18 | Eisai Inc. ($9,752) |
| 2020 | $2,400 | 2 | Harmony Biosciences LLC ($2,400) |
| 2019 | $7,666 | 23 | JAZZ PHARMACEUTICALS INC. ($7,216) |
| 2018 | $6,218 | 9 | Jazz Pharmaceuticals Inc. ($6,097) |
| 2017 | $575.00 | 1 | Allergan Inc. ($575.00) |
All Payment Transactions
123 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $144.72 | General |
| Category: NEUROLOGY | ||||||
| 09/23/2024 | 3B Medical, Inc. | LUNA (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: VENTILATOR, NON-CONTINUOUS (RESPIRATOR) | ||||||
| 09/18/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: NEUROLOGY | ||||||
| 06/20/2024 | 3B Medical, Inc. | LUNA (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: VENTILATOR, NON-CONTINUOUS (RESPIRATOR) | ||||||
| 06/04/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $30.62 | General |
| Category: Narcoplepsy | ||||||
| 06/03/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: NEUROLOGY | ||||||
| 06/03/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $87.50 | General |
| Category: Insomnia | ||||||
| 06/02/2024 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug) | Food and Beverage | In-kind items and services | $182.83 | General |
| Category: NEUROLOGY | ||||||
| 05/30/2024 | 3B Medical, Inc. | LUNA (Device) | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| Category: VENTILATOR, NON-CONTINUOUS (RESPIRATOR) | ||||||
| 05/16/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $62.50 | General |
| Category: Insomnia | ||||||
| 04/11/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Consulting Fee | Cash or cash equivalent | $1,563.00 | General |
| Category: Narcoplepsy | ||||||
| 01/31/2024 | EnsoData, Inc. | — | Consulting Fee | Cash or cash equivalent | $79,999.92 | General |
| 12/18/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $817.00 | General |
| 11/17/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $2,725.00 | General |
| 11/09/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | Cash or cash equivalent | $74.00 | General |
| Category: INSOMNIA | ||||||
| 11/09/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $47.24 | General |
| Category: INSOMNIA | ||||||
| 11/09/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: INSOMNIA | ||||||
| 11/09/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: INSOMNIA | ||||||
| 11/07/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Consulting Fee | Cash or cash equivalent | $10,627.50 | General |
| Category: INSOMNIA | ||||||
| 10/21/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $3,814.00 | General |
| 08/18/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Consulting Fee | Cash or cash equivalent | $2,180.00 | General |
| Category: INSOMNIA | ||||||
| 07/17/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Consulting Fee | Cash or cash equivalent | $1,042.00 | General |
| Category: SLEEP MEDICINE | ||||||
| 06/23/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Consulting Fee | Cash or cash equivalent | $4,360.00 | General |
| Category: INSOMNIA | ||||||
| 06/19/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,632.50 | General |
| Category: INSOMNIA | ||||||
| 06/19/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | Cash or cash equivalent | $487.80 | General |
| Category: INSOMNIA | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| CLINCIAL PRACTICE GUIDELINES ON SWITCHING HYPNOTIC MEDICINES (CONSENSUS; PUBLICATION) | IDORSIA PHARMACEUTICALS US INC | $10,073 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 179 | 188 | $49,549 | $13,019 |
| 2022 | 4 | 154 | 167 | $41,691 | $11,901 |
| 2021 | 8 | 228 | 258 | $62,306 | $19,535 |
| 2020 | 6 | 162 | 175 | $37,817 | $11,188 |
Total Patients
723
Total Services
788
Medicare Billing
$55,642
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 53 | 60 | $14,938 | $4,172 | 27.9% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 33 | 33 | $12,465 | $3,310 | 26.6% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 25 | 26 | $10,158 | $2,583 | 25.4% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Facility | 2023 | 56 | 57 | $7,346 | $1,839 | 25.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 12 | 12 | $4,643 | $1,115 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 65 | 78 | $16,940 | $5,515 | 32.6% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 37 | 37 | $14,257 | $3,465 | 24.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 11 | 11 | $3,953 | $1,089 | 27.6% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Facility | 2022 | 29 | 29 | $3,865 | $991.78 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 12 | $2,676 | $840.20 | 31.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 66 | 93 | $19,911 | $7,511 | 37.7% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Facility | 2021 | 50 | 50 | $18,869 | $5,042 | 26.7% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Facility | 2021 | 15 | 15 | $5,879 | $1,627 | 27.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 14 | 14 | $4,920 | $1,532 | 31.1% |
| 95800 | Study of sleep patterns, including sleep time | Facility | 2021 | 39 | 41 | $5,301 | $1,321 | 24.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 14 | 14 | $3,061 | $1,039 | 34.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 18 | 18 | $2,506 | $993.29 | 39.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 12 | 13 | $1,859 | $469.28 | 25.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 52 | 64 | $12,666 | $3,772 | 29.8% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Facility | 2020 | 33 | 33 | $12,336 | $3,499 | 28.4% |
| 95800 | Study of sleep patterns | Facility | 2020 | 42 | 42 | $5,439 | $1,375 | 25.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 11 | 11 | $3,581 | $1,132 | 31.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 12 | 12 | $2,352 | $827.14 | 35.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 12 | 13 | $1,444 | $582.49 | 40.3% |
About Dr. Nathaniel Watson, MD
Dr. Nathaniel Watson, MD is a Neurology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528144342.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nathaniel Watson, MD has received a total of $352,101 in payments from pharmaceutical and medical device companies, with $86,991 received in 2024. These payments were reported across 123 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($306,031).
As a Medicare-enrolled provider, Watson has provided services to 723 Medicare beneficiaries, totaling 788 services with total Medicare billing of $55,642. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Seattle, WA
- Active Since 10/27/2006
- Last Updated 01/24/2012
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1528144342
Products in Payments
- QUVIVIQ (Drug) $72,359
- Wakix (Drug) $11,543
- Dayvigo (Drug) $9,752
- SUNOSI (Drug) $7,216
- XYWAV (Drug) $6,315
- LUNA (Device) $4,750
- WAKIX (Drug) $3,968
- XYREM (Drug) $182.83
- Fycompa (Drug) $120.97
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Seattle
Dr. Pavle Repovic, Md, Phd, MD, PHD
Neurology — Payments: $1.2M
Neurology $1.2M
Mariko Kita, Md, MD
Neurology — Payments: $243,050
Neurology $243,050
Kyra Becker
Neurology — Payments: $239,174
Neurology $239,174
Christyn Edmundson, Md, MD
Neurology — Payments: $226,530
Neurology $226,530
Pravin Khemani, Md, MD
Neurology — Payments: $199,884
Neurology $199,884
Yince Loh, M.d, M.D
Neurology — Payments: $177,017
Neurology $177,017